Advances in immunotherapy for glioblastoma multiforme

Glioblastoma multiforme (GBM) is the most common and aggressive malignant brain tumor of the central nervous system and has a very poor prognosis. The current standard of care for patients with GBM involves surgical resection, radiotherapy, and chemotherapy. Unfortunately, conventional therapies hav...

Full description

Bibliographic Details
Main Authors: Mahmoud, Ahmad Bakur, Ajina, Reham, Aref, Sarah, Darwish, Manar, Alsayb, May, Taher, Mustafa, AlSharif, Shaker A., Hashem, Anwar M., Alkayyal, Almohanad A.
Format: Online Article Text
Language:English
Published: Frontiers Media S.A. 2022
Subjects:
Immunology
Online Access:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9597698/
https://www.ncbi.nlm.nih.gov/pubmed/36311781
http://dx.doi.org/10.3389/fimmu.2022.944452

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9597698/
https://www.ncbi.nlm.nih.gov/pubmed/36311781
http://dx.doi.org/10.3389/fimmu.2022.944452

Similar Items